Pharma Elite provides world-class Regulatory Affairs Consultant Egypt services designed to navigate the complex landscape of global pharmaceutical regulations. Our expert team acts as your strategic partner, guiding you through every step of the product lifecycle—from initial development strategy to marketing authorization and post-approval maintenance.
We specialize in submissions for the Egyptian Drug Authority (EDA), Saudi Food & Drug Authority (SFDA), and other MENA region authorities, as well as international bodies like the FDA and EMA. Our deep understanding of local and international guidelines ensures that your submissions are accurate, compliant, and optimized for fast approval.
Development of tailored regulatory roadmaps for product development, registration, and market launch.
Expert preparation, review, and management of regulatory submissions including MAA, NDA, and CTD preparation.
Ongoing support for variations, renewals, line extensions, and Post-Marketing Variation Management.
Support for scientific advice meetings, pre-submission meetings, and responses to regulatory queries.
Continuous monitoring of global regulatory changes and trends
Identifying and addressing missing data or compliance risks
Ensuring high-quality, compliant documentation
Adherence to strict regulatory standards and ethical guidelines
Experts in US FDA requirements for drugs, biologics, and devices.
In-depth knowledge of European Medicines Agency procedures (Centralized, DCP, MRP).
Specialized expertise in SFDA (Saudi Arabia), MOH (UAE), and other regional health authorities.
Full compliance with International Council for Harmonisation guidelines.
For companies targeting the Kingdom of Saudi Arabia, compliance with the SFDA Track & Trace (Rasad) system is mandatory. We guide you through the registration on the GHAD System, ensuring your products met all serialization and aggregation requirements.
Our team handles the complete SFDA registration process, including classification, eCTD submission via the GHAD portal, and responding to authority inquiries to secure your Marketing Authorization quickly.
We cover the Egyptian Drug Authority (EDA), Saudi Food & Drug Authority (SFDA), MOH in UAE, Kuwait, Oman, Bahrain, and Qatar, as well as the US FDA, EMA (Europe), and other African regulatory bodies.
Yes, we manage the entire registration pathway from defining the regulatory strategy and gap analysis to dossier compilation, submission, and handling agency queries until final approval.
Yes, our scope extends beyond pharmaceuticals to include regulatory support for medical devices, cosmetics, and food supplements, ensuring compliance with their specific regulatory frameworks.
The SFDA registration fees vary depending on the product type (human drug, herbal, veterinary, medical device) and the type of application. We can provide a detailed cost breakdown as part of our initial feasibility assessment.
We maintain a high approval rate due to our rigorous internal quality checks, gap analysis processes, and strict adherence to the latest updated regulatory guidelines for each target region.
We maintain a high approval rate due to our rigorous internal quality checks, gap analysis processes, and strict adherence to the latest updated regulatory guidelines for each target region.